Lingbing Meng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lingbing Meng has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Jiawen Yin
Department of Neurology, Institute of Geriatric Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, China
1 shared publication - Li Wang
Department of Neurology, The Affiliated Hospital of Northwest University, Xi’an No.3 Hospital, Xi’an, China
1 shared publication - Qianwen Wang
Department of Neurology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, No. 1 DaHua Road, Dong Dan, Beijing 100730, China
1 shared publication - Tao Gong
Neurology Department, Beijing Hospital,National Center for Gerontology;National Clinical Research Center for Gerontology;The Key Laboratory of Geriatrics of NHC;Institute of Geriatric Medicine,Chinese Academy of Medical Sciences, Beijing, China
1 shared publication - Yuhui Chen
Department of Neurology, Institute of Geriatric Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 28 July 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (8) , 1000
A Novel Perspective on Ischemic Stroke: A Review of Exosome and Noncoding RNA Studies
Ischemic stroke is a life-threatening condition that also frequently results in long-term disability. Currently, intravenous thrombolysis with tissue plasminogen activator and mechanical thrombectomy is the most popular treatment. However, the narrow time window and related complications limit the treatment benefits. Exosomes have recently emerged as ideal therapeutic candidates for ischemic stroke with the ability to pass through the blood_brain barrier and mediate intercellular communication, in addition, exosomes and their contents can be bioengineered to implement targeted delivery. In the last two decades, exosomes and exosomal noncoding RNAs have been found to be involved in the pathophysiological progression of ischemic stroke, including atherosclerosis, apoptosis, inflammation, oxidative stress, and neurovascular remodeling. In this review, we describe the latest progress regarding the role of exosomal long noncoding RNAs and circular RNAs in the occurrence, progression, and recovery of ischemic stroke. Exploration of exosomal noncoding RNAs and their correlated effects in ischemic stroke may facilitate accurate diagnosis, and they may serve as new therapeutic targets for the disease.
- 28 July 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (8) , 1000
Open AccessA Novel Perspective on Ischemic Stroke: A Review of Exosome and Noncoding RNA Studies
Ischemic stroke is a life-threatening condition that also frequently results in long-term disability. Currently, intravenous thrombolysis with tissue plasminogen activator and mechanical thrombectomy is the most popular treatment. However, the narrow time window and related complications limit the treatment benefits. Exosomes have recently emerged as ideal therapeutic candidates for ischemic stroke with the ability to pass through the blood_brain barrier and mediate intercellular communication, in addition, exosomes and their contents can be bioengineered to implement targeted delivery. In the last two decades, exosomes and exosomal noncoding RNAs have been found to be involved in the pathophysiological progression of ischemic stroke, including atherosclerosis, apoptosis, inflammation, oxidative stress, and neurovascular remodeling. In this review, we describe the latest progress regarding the role of exosomal long noncoding RNAs and circular RNAs in the occurrence, progression, and recovery of ischemic stroke. Exploration of exosomal noncoding RNAs and their correlated effects in ischemic stroke may facilitate accurate diagnosis, and they may serve as new therapeutic targets for the disease.